Fundraising Fox

Biotech Investors & VC Firms in Global

642 firms in this list, with a median first check of $500K. 156 of them lead rounds. Generated from verified public data and updated continuously.

Finchley Healthcare Ventures
MontrealSeed–Late Stage
15 people
NDI
ClevelandSeed–Series A
14 people
Asia2G Capital
Silicon ValleyPre-Seed–Series A
6 people
Building Global Innovators
LisbonPre-Seed–Seed
15 people
Blindspot Ventures Management Co
BostonPre-Seed–Late Stage
5 people
Invus
New YorkPre-Seed–Late Stage
8 people
FTW Ventures
San FranciscoPre-Seed–Series A$100K – $500K
4 people
Venture Capital Investment Management
San FranciscoSeed–Series A
7 people
Vespucci Partners
BudapestSeed–Series A$648K – $4.9M
7 people
China Growth Capital
BeijingPre-Seed–Series A$1M – $55M
HB Ventures
ViennaSeed–Growth$1M – $10M
9 people
Masia
BarcelonaPre-Seed–Seed$135K – $270K
23andMe
Mountain View
14 people
Fab Co-Creation Studio Ventures
San FranciscoPre-Seed–Series A$250K – $1M
3 people
Tetragon Financial Group Limited
LondonSeries C
12 people
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
11 people
Amgen Ventures
Thousand OaksSeed–Late Stage$1M – $3M
6 people
Taiho Ventures, LLC
Menlo ParkSeed–Series B
6 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
Amplitude Venture Capital
MontrealSeed–Late Stage
14 people
Samho Green Investment, Inc.
SeoulSeed–Late Stage$500K – $10M
11 people
Angelini Ventures
RomeSeed–Growth
4 people
Outset Ventures
AucklandPre-Seed–Growth$100K – $10M
2 people
BOLD Longevity
BostonGrowth–Late Stage
10 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.